Division of Pediatric Nephrology, Dialysis and Transplantation, Helen Devos Children's Hospital and Clinics, , Grand Rapids, MI 49503, USA.
Curr Diab Rep. 2009 Dec;9(6):473-9. doi: 10.1007/s11892-009-0077-7.
Diabetes is the most common cause of end-stage renal disease in industrialized countries. This article describes the structural changes in early diabetic nephropathy and the relationship with renal functional parameters, blood pressure, and albumin excretion. The detrimental influence of sustained hyperglycemia and/or glycemic fluctuations on renal structural change has been well documented. Tight glycemic control is paramount to preventing the development, and even the regression, of renal lesions. As much of the renal injury from diabetes occurs in clinical silence before symptoms or laboratory findings of renal injury are evident, finding early markers of risk is imperative so that nephropathy can be prevented. Currently, the only clinical surrogate marker of diabetic renal injury available is microalbuminuria. However, given the reports of regression of microalbuminuria back to normoalbuminuria, the reliability of this tool as an indicator of risk has been questioned. The need for alternative, noninvasive surrogate markers is described in this report.
糖尿病是工业化国家终末期肾病的最常见病因。本文描述了早期糖尿病肾病的结构变化,以及与肾功能参数、血压和白蛋白排泄的关系。持续高血糖和/或血糖波动对肾脏结构变化的有害影响已有充分的文献记载。严格的血糖控制对于预防肾脏病变的发生,甚至是逆转肾脏病变至关重要。由于糖尿病引起的大部分肾损伤在出现肾脏损伤的症状或实验室发现之前,在临床中都处于无声状态,因此寻找早期风险标志物至关重要,以便能够预防肾病。目前,唯一可用的糖尿病肾损伤的临床替代标志物是微量白蛋白尿。然而,鉴于微量白蛋白尿回归正常白蛋白尿的报道,该工具作为风险指标的可靠性受到了质疑。本报告描述了对替代的、非侵入性替代标志物的需求。